Sarepta Therapeutics (NASDAQ:SRPT) stock is up approximately 20% in early trading on Wednesday after the company released its ...
Sarepta Therapeutics Inc. (NASDAQ:SRPT) is one of the 10 Stocks Investors Are Buying Now. Sarepta Therapeutics soared by ...
Sarepta Therapeutics (SRPT) shares soared 35% in the last trading session to close at $23.77. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...
Sarepta (SRPT) stock rises on positive Phase 1/2 siRNA trial data showing muscle delivery, biomarker activity, and safety in ...
Shares of Sarepta Therapeutics SRPT rose 35% on Wednesday after the company announced early clinical data on two experimental ...
Sarepta Therapeutics is navigating a transition from a profitable rare-disease company to a capital-intensive, multi-platform ...
Sarepta Therapeutics (SRPT) stock jumps as the company posts early data from Phase 1/2 trials for its experimental muscular ...
LOS ANGELES, Aug. 25, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Sarepta Therapeutics, Inc. ("Sarepta" or "the Company") (NASDAQ: SRPT) for violations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results